Trials / Completed
CompletedNCT01534650
Movement Disorder Quantification Algorithm Development
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17 (actual)
- Sponsor
- Great Lakes NeuroTechnologies Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to collect kinematic motion data from subjects with movement disorders such as Parkinson's disease (PD) and essential tremor (ET) to develop and validate algorithms for quantifying motor symptoms such as tremor, bradykinesia (slowed movements), dyskinesias (sudden, involuntary movements), gait, and balance during standardized tasks and/or activities of daily living.
Conditions
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2012-02-17
- Last updated
- 2017-02-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01534650. Inclusion in this directory is not an endorsement.